Overview
Russell Pachynski is an Oncologist practicing medicine in Saint Louis, Missouri.
Dr. Pachynski is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), and Muscle Invasive Bladder Cancer.
He is actively involved in clinical research, co-authoring 69 peer reviewed articles and participating in 19 clinical trials.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
10 Barnes West Dr, Saint Louis, MO 63141
660 S Euclid Ave, Saint Louis, MO 63110
Additional Areas of Focus
Dr. Pachynski has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
19 Clinical Trials
Washington University School Of Medicine
Nancy Bartlett is an Oncologist practicing medicine in Saint Louis, Missouri. Dr. Bartlett is highly rated in 34 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Hodgkin Lymphoma, B-Cell Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.
Washington University School Of Medicine
Ramaswamy Govindan is an Oncologist practicing medicine in Saint Louis, Missouri. Dr. Govindan is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma.
Washington University
David Mutch is an Oncologist practicing medicine in Saint Louis, Missouri. Dr. Mutch is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Vulvar Cancer, Hysterectomy, and Tubal Ligation.
Frequently Asked Questions about Dr. Russell Pachynski
How do I make an appointment with Dr. Russell Pachynski?
You can book an appointment with Dr. Russell Pachynski by calling their office at 314-996-8270. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Russell Pachynski a top-rated expert for Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Russell Pachynski is classified as an Elite expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Russell Pachynski specialize in?
While Dr. Russell Pachynski is a Oncology, they have specific expertise in Prostate Cancer, Familial Prostate Cancer, and Renal Cell Carcinoma (RCC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Russell Pachynski participate in research or clinical trials?
Yes. Dr. Russell Pachynski has published 69 articles and abstracts on conditions like Prostate Cancer. You can view a list of Dr. Russell Pachynski's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Russell Pachynski accept my insurance?
Dr. Russell Pachynski accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 314-996-8270 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Prostate CancerDr. Pachynski isElite. Learn about Prostate Cancer.
- Distinguished
- Familial Prostate CancerDr. Pachynski isDistinguished. Learn about Familial Prostate Cancer.
- Advanced
- Chromophobe Renal Cell CarcinomaDr. Pachynski isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Pachynski isAdvanced. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Dr. Pachynski isAdvanced. Learn about Familial Wilms Tumor 2.
- Muscle Invasive Bladder CancerDr. Pachynski isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Renal Cell Carcinoma (RCC)Dr. Pachynski isAdvanced. Learn about Renal Cell Carcinoma (RCC).
- Urothelial CancerDr. Pachynski isAdvanced. Learn about Urothelial Cancer.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Pachynski isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Adrenal CancerDr. Pachynski isExperienced. Learn about Adrenal Cancer.
- Adrenocortical CarcinomaDr. Pachynski isExperienced. Learn about Adrenocortical Carcinoma.
- Adult Soft Tissue SarcomaDr. Pachynski isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Pachynski isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Pachynski isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.